This work examines how composite scores (CS) of re-weighted combinations of the MDS-UPDRS PART II items can better detect meaningful changes and increase success for efficacious disease-modifying treatments.
No takes yet. Share an insight, caveat, or question.
Dickson et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: